Approval · Notice of Compliance 24087 · 2020
HEPSERA: Notice of Compliance 24087
Issued August 20, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24087
- Date
- August 20, 2020
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the Product Monograph with the drug-drug interaction with products containing tenofovir alafenamide (TAF)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HEPSERA | 02247823 | Cancelled Post Market |
Medicinal ingredients
- ADEFOVIR DIPIVOXIL 10 MG per TAB